4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosylpiperidine, 95%, 5g

Methyl 3-amino-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95.0%, 250mg

1-Chloroisoquinoline-4-carboxylic acid methyl ester, 95.0%, 100mg

3-((2-Bromophenyl)amino)cyclohex-2-enone, 95%, 250mg

(4-(((Benzyloxy)carbonyl)(ethyl)amino)phenyl)boronic acid, 95.0%, 5g

2-Phenyl-1H-indol-5-amine, 95.0%, 1g

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole, 95.0%, 25g

5-(4-Fluoro-phenyl)-N-hydroxy-2-methyl-furan-3-carboxamidine, 95.0%, 1g

Übergangsstück, mit Normschliffen, DURAN®, NS Hülse 24/29, NS Kern 14/23, 1 Stück

2-(cyclopropylamino)-2-(pyridin-3-yl)acetic acid, 95.0%, 250mg

2-Amino-5-cyano-4-phenylthiazole, 1g

6-(METHYLTHIO)-1H-PYRAZOLO[3,4-D]PYRIMIDINE, 95%, 250mg

4-(2-(Piperidin-1-yl)ethoxy)benzoic acid hydrochloride, 95.0%, 25g